Company Overview of Inverseon, Inc.
As of August 30, 2012, Inverseon, Inc. was acquired by Invion Limited. Invion Limited, a clinical-stage drug development company, focuses on the treatments for anti-inflammatory diseases. It focuses on the development of treatments for asthma, chronic bronchitis, and lupus.
1701 Jackson Street
San Francisco, CA 94109
Founded in 2004
Key Executives for Inverseon, Inc.
Inverseon, Inc. does not have any Key Executives recorded.
Similar Private Companies By Industry
|21st Century Animal Health||United States|
|3 Buds' Organics LLC||United States|
|4P Therapeutics LLC||United States|
|60° Pharmaceuticals, LLC||United States|
|7 Oaks Pharmaceutical Corp.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|The Advertising Council, Inc.||United States|
Sponsored Financial Commentaries
To contact Inverseon, Inc., please visit www.inverseon.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.